应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PCSA Processa Pharmaceuticals, Inc.
休市中 03-14 16:00:00 EDT
0.4467
-0.0008
-0.18%
盘后
0.4505
+0.0038
+0.84%
17:58 EDT
最高
0.4744
最低
0.4200
成交量
4.89万
今开
0.4425
昨收
0.4475
日振幅
12.17%
总市值
211.61万
流通市值
183.09万
总股本
473.73万
成交额
2.12万
换手率
1.19%
流通股本
409.88万
市净率
0.57
ROE
-211.71%
每股收益
-4.55
52周最高
3.31
52周最低
0.4200
市盈率
-0.10
股息
0.00
股息收益率
0.00
ROA
-113.11%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.74%报0.515美元
市场透视 · 03-10
Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.74%报0.515美元
Processa Pharmaceuticals, Inc.盘中异动 下午盘股价大跌7.66%
市场透视 · 03-06
Processa Pharmaceuticals, Inc.盘中异动 下午盘股价大跌7.66%
Processa Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.80%
市场透视 · 03-04
Processa Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.80%
Processa Pharmaceuticals, Inc.盘中异动 大幅下挫5.26%报0.520美元
市场透视 · 03-03
Processa Pharmaceuticals, Inc.盘中异动 大幅下挫5.26%报0.520美元
Processa Pharmaceuticals, Inc.盘中异动 急速跳水5.67%报0.516美元
市场透视 · 02-27
Processa Pharmaceuticals, Inc.盘中异动 急速跳水5.67%报0.516美元
Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.23%
市场透视 · 02-25
Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.23%
Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.55%报0.559美元
市场透视 · 02-24
Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.55%报0.559美元
Processa Pharmaceuticals, Inc.盘中异动 大幅上涨7.25%
市场透视 · 02-21
Processa Pharmaceuticals, Inc.盘中异动 大幅上涨7.25%
Processa Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.72%报0.565美元
市场透视 · 02-19
Processa Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.72%报0.565美元
Processa Pharmaceuticals, Inc.盘中异动 大幅上涨5.82%
市场透视 · 02-18
Processa Pharmaceuticals, Inc.盘中异动 大幅上涨5.82%
Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.03%
市场透视 · 02-11
Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.03%
Processa Pharmaceuticals, Inc.盘中异动 股价大跌8.30%报0.603美元
市场透视 · 02-10
Processa Pharmaceuticals, Inc.盘中异动 股价大跌8.30%报0.603美元
Processa Pharmaceuticals, Inc.盘中异动 快速上涨5.04%报0.625美元
市场透视 · 02-07
Processa Pharmaceuticals, Inc.盘中异动 快速上涨5.04%报0.625美元
Processa Pharmaceuticals, Inc.盘中异动 快速跳水5.79%
市场透视 · 02-05
Processa Pharmaceuticals, Inc.盘中异动 快速跳水5.79%
Processa Pharmaceuticals, Inc.盘中异动 早盘大幅跳水6.14%
市场透视 · 02-03
Processa Pharmaceuticals, Inc.盘中异动 早盘大幅跳水6.14%
Processa Pharmaceuticals, Inc.盘中异动 急速跳水6.14%
市场透视 · 01-31
Processa Pharmaceuticals, Inc.盘中异动 急速跳水6.14%
Processa Pharmaceuticals, Inc.股价上涨17.02% 市值涨55.88万美元
市场透视 · 01-30
Processa Pharmaceuticals, Inc.股价上涨17.02% 市值涨55.88万美元
Processa Pharmaceuticals, Inc.盘中异动 股价大跌7.98%报0.542美元
市场透视 · 01-29
Processa Pharmaceuticals, Inc.盘中异动 股价大跌7.98%报0.542美元
Processa Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.00%
市场透视 · 01-28
Processa Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.00%
Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.26%
市场透视 · 01-27
Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.26%
加载更多
公司概况
公司名称:
Processa Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Processa Pharmaceuticals, Inc.成立于2011年3月29日。该公司是一家临床阶段的生物制药公司,致力于药物产品的开发,该产品旨在为高度未满足的患者提供治疗方法并改善其生存率和生活质量。
发行价格:
--
{"stockData":{"symbol":"PCSA","market":"US","secType":"STK","nameCN":"Processa Pharmaceuticals, Inc.","latestPrice":0.4467,"timestamp":1741982400000,"preClose":0.4475,"halted":0,"volume":48919,"hourTrading":{"tag":"盘后","latestPrice":0.45046,"preClose":0.4467,"latestTime":"17:58 EDT","volume":226,"amount":101.7986,"timestamp":1741989531372},"delay":0,"floatShares":4098800,"shares":4737288,"eps":-4.54768,"marketStatus":"休市中","change":-0.0008,"latestTime":"03-14 16:00:00 EDT","open":0.4425,"high":0.474449,"low":0.42,"amount":21223.095274,"amplitude":0.121674,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-4.54768,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1742198400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4475,"preHourTrading":{"tag":"盘前","latestPrice":0.475,"preClose":0.4475,"latestTime":"08:57 EDT","volume":1365,"amount":638.61252,"timestamp":1741957069521},"postHourTrading":{"tag":"盘后","latestPrice":0.45046,"preClose":0.4467,"latestTime":"17:58 EDT","volume":226,"amount":101.7986,"timestamp":1741989531372},"volumeRatio":0.8725439161172869},"requestUrl":"/m/hq/s/PCSA","defaultTab":"news","newsList":[{"id":"2518274630","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.74%报0.515美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518274630?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613578,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分,Processa Pharmaceuticals, Inc.股票出现波动,股价大幅上涨6.74%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.18%。其相关个股中,Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为2042.36%、403.78%、59.56%,振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.,振幅分别为99.91%、99.13%、98.72%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213258a26a251e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213258a26a251e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2517192858","title":"Processa Pharmaceuticals, Inc.盘中异动 下午盘股价大跌7.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517192858?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:39","pubTimestamp":1741289990,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时39分,Processa Pharmaceuticals, Inc.股票出现波动,股价快速跳水7.66%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.74%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033951abebc101&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033951abebc101&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2516038626","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516038626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516038626?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:26","pubTimestamp":1741101968,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时26分,Processa Pharmaceuticals, Inc.股票出现异动,股价急速下挫5.80%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.29%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232608abe7ffc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232608abe7ffc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2516634054","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅下挫5.26%报0.520美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516634054?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:44","pubTimestamp":1741013066,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时44分,Processa Pharmaceuticals, Inc.股票出现异动,股价快速跳水5.26%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。其相关个股中,Entero Therapeutics Inc.、Aldeyra Therapeutics, Inc.、Geovax Labs, Inc.涨幅较大,Entero Therapeutics Inc.、Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为99.60%、52.65%、43.38%,振幅较大的相关个股有Entero Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ,振幅分别为55.45%、24.83%、22.27%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224426989a1333&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224426989a1333&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2514633316","title":"Processa Pharmaceuticals, Inc.盘中异动 急速跳水5.67%报0.516美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514633316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514633316?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:23","pubTimestamp":1740677027,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时23分,Processa Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.67%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。其相关个股中,Pepgen Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Ibio, Inc.涨幅较大,Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为1719.86%、295.31%、124.40%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Quoin Pharmaceuticals Ltd,振幅分别为86.14%、50.65%、47.79%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022801234798953193&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022801234798953193&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2514166350","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514166350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514166350?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:39","pubTimestamp":1740497961,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时39分,Processa Pharmaceuticals, Inc.股票出现波动,股价快速下跌5.23%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.84%。其相关个股中,Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大,Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为1085.21%、1053.80%、602.38%,振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp,振幅分别为224.93%、64.05%、61.16%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523392198925bb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523392198925bb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2513778982","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.55%报0.559美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513778982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513778982?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:10","pubTimestamp":1740409852,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时10分,Processa Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.55%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.62%。其相关个股中,Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大,Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为173.39%、74.39%、26.10%,振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ,振幅分别为137.23%、55.69%、53.34%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231052abdb176f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231052abdb176f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2513329667","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅上涨7.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513329667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513329667?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:35","pubTimestamp":1740148554,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时35分,Processa Pharmaceuticals, Inc.股票出现异动,股价快速上涨7.25%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。其相关个股中,Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.涨幅较大,Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃,换手率分别为72.73%、65.34%、16.78%,振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Osr Holdings Inc C/Wts 09/02/2028 、Osr Holdings, Inc.,振幅分别为33.83%、30.00%、25.39%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223554962b7c50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223554962b7c50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2512335435","title":"Processa Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.72%报0.565美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512335435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512335435?lang=zh_cn&edition=full","pubTime":"2025-02-20 02:57","pubTimestamp":1739991478,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日02时57分,Processa Pharmaceuticals, Inc.股票出现异动,股价大幅下跌5.72%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.53%。其相关个股中,Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大,Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃,换手率分别为670.86%、254.32%、228.87%,振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Surrozen Inc C/Wts 01/08/2031 ,振幅分别为267.43%、159.49%、65.50%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200257599628f7ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200257599628f7ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2512816608","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅上涨5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512816608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512816608?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:44","pubTimestamp":1739889842,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时44分,Processa Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.82%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.62%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224402abd3b212&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224402abd3b212&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2510380597","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380597?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:38","pubTimestamp":1739284704,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时38分,Processa Pharmaceuticals, Inc.股票出现异动,股价快速下跌5.03%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.92%。其相关个股中,Dominari Holdings Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2198.59%、560.12%、212.79%,振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.,振幅分别为31.80%、26.96%、25.49%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223824a241fcce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223824a241fcce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2510892585","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌8.30%报0.603美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510892585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510892585?lang=zh_cn&edition=full","pubTime":"2025-02-11 04:07","pubTimestamp":1739218041,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日04时07分,Processa Pharmaceuticals, Inc.股票出现波动,股价大幅下跌8.30%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.92%。其相关个股中,Dominari Holdings Inc.、知临集团、Nls Pharmaceutics Ltd.涨幅较大,Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃,换手率分别为3176.57%、1685.60%、1446.79%,振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Biodexa Pharmaceuticals Plc、Abpro Holdings Inc C/Wts 12/11/2029 ,振幅分别为99.86%、95.28%、87.80%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110407219880b839&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110407219880b839&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2509231720","title":"Processa Pharmaceuticals, Inc.盘中异动 快速上涨5.04%报0.625美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509231720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509231720?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:05","pubTimestamp":1738955147,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时05分,Processa Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.04%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.60%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208030547abc662e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208030547abc662e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2509251489","title":"Processa Pharmaceuticals, Inc.盘中异动 快速跳水5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509251489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509251489?lang=zh_cn&edition=full","pubTime":"2025-02-06 05:00","pubTimestamp":1738789238,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日05时00分,Processa Pharmaceuticals, Inc.股票出现异动,股价大幅下挫5.79%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.97%。其相关个股中,Immatics N V C/Wts 01/07/2025 、Invivyd, Inc.、Transcode Therapeutics, Inc.涨幅较大,Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃,换手率分别为4746.48%、2458.28%、1792.11%,振幅较大的相关个股有Oragenics Inc.、Invivyd, Inc.、Transcode Therapeutics, Inc.,振幅分别为132.24%、108.79%、99.51%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206050038abc3ccef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206050038abc3ccef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2508014922","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘大幅跳水6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508014922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508014922?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:34","pubTimestamp":1738593289,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时34分,Processa Pharmaceuticals, Inc.股票出现异动,股价快速下跌6.14%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.39%。其相关个股中,Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大,Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃,换手率分别为349.46%、298.80%、137.26%,振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.,振幅分别为57.23%、33.33%、26.50%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322344998796f8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322344998796f8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2507663219","title":"Processa Pharmaceuticals, Inc.盘中异动 急速跳水6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507663219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507663219?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:36","pubTimestamp":1738334205,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时36分,Processa Pharmaceuticals, Inc.股票出现波动,股价急速跳水6.14%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.54%。其相关个股中,Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃,换手率分别为1413.08%、255.53%、64.36%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nutriband Inc C/Wts 、Nls Pharmaceutics Ltd.,振幅分别为62.40%、42.27%、30.81%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223645a2354341&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223645a2354341&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2507219556","title":"Processa Pharmaceuticals, Inc.股价上涨17.02% 市值涨55.88万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507219556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507219556?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:31","pubTimestamp":1738247475,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时31分,Processa Pharmaceuticals, Inc.股票出现异动,股价急速拉升17.02%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大,Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃,换手率分别为583.70%、118.42%、93.09%,振幅较大的相关个股有Tectonic Therapeutic, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Alterity Therapeutics Limited,振幅分别为17.92%、15.36%、10.65%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223115abbd4bfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223115abbd4bfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2507631907","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌7.98%报0.542美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507631907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507631907?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:33","pubTimestamp":1738161204,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时33分,Processa Pharmaceuticals, Inc.股票出现波动,股价急速下跌7.98%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012922332498760a58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012922332498760a58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2506545517","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506545517","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506545517?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:39","pubTimestamp":1738075196,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时39分,Processa Pharmaceuticals, Inc.股票出现异动,股价大幅下跌5.00%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223956abbb67e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223956abbb67e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2506304431","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506304431","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506304431?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:23","pubTimestamp":1737995031,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时23分,Processa Pharmaceuticals, Inc.股票出现波动,股价急速下跌5.26%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.93%。其相关个股中,Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大,Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃,换手率分别为2033.66%、483.93%、221.70%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为86.84%、85.35%、65.16%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128002352a231829e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128002352a231829e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.processapharmaceuticals.com","stockEarnings":[{"period":"1week","weight":-0.0742},{"period":"1month","weight":-0.2672},{"period":"3month","weight":-0.5976},{"period":"6month","weight":-0.6666},{"period":"1year","weight":-0.7997},{"period":"ytd","weight":-0.4946}],"compareEarnings":[{"period":"1week","weight":-0.0228},{"period":"1month","weight":-0.0672},{"period":"3month","weight":-0.0685},{"period":"6month","weight":0.0014},{"period":"1year","weight":0.0929},{"period":"ytd","weight":-0.0397}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Processa Pharmaceuticals, Inc.成立于2011年3月29日。该公司是一家临床阶段的生物制药公司,致力于药物产品的开发,该产品旨在为高度未满足的患者提供治疗方法并改善其生存率和生活质量。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.248045},{"month":2,"riseRate":0.571429,"avgChangeRate":0.073235},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.107269},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.072959},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.095736},{"month":6,"riseRate":0.714286,"avgChangeRate":0.170494},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.109157},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.10415},{"month":9,"riseRate":0.571429,"avgChangeRate":0.100987},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.118178},{"month":11,"riseRate":0.428571,"avgChangeRate":0.093414},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.169338}],"exchange":"NASDAQ","name":"Processa Pharmaceuticals, Inc.","nameEN":"Processa Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.7","shortVersion":"4.31.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Processa Pharmaceuticals, Inc.,PCSA,Processa Pharmaceuticals, Inc.股票,Processa Pharmaceuticals, Inc.股票老虎,Processa Pharmaceuticals, Inc.股票老虎国际,Processa Pharmaceuticals, Inc.行情,Processa Pharmaceuticals, Inc.股票行情,Processa Pharmaceuticals, Inc.股价,Processa Pharmaceuticals, Inc.股市,Processa Pharmaceuticals, Inc.股票价格,Processa Pharmaceuticals, Inc.股票交易,Processa Pharmaceuticals, Inc.股票购买,Processa Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}